Trial Profile
Improving Single Donor Success Rate in Clinical Islet Transplantation Using Alpha-1 Antitrypsin (Aralast NP)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- 22 Oct 2019 Status changed from active, no longer recruiting to completed.
- 15 Apr 2019 Planned End Date changed from 1 Mar 2020 to 1 Mar 2021.
- 15 Apr 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.